{"entity":"novartis","id":"ent_novartis","name":"Novartis","wikidata":"Q507154","page":"https://asof.is/record/novartis","summary":"Novartis is a Swiss-American multinational pharmaceutical corporation, headquartered in Basel. Its CEO is Vasant (Vas) Narasimhan, since 2018.","title":"Novartis: CEO Vasant (Vas) Narasimhan","key_facts":[{"label":"CEO","value":"Vasant (Vas) Narasimhan","note":"since 2018","claim":"clm_3312D1223526"},{"label":"Headquarters","value":"Basel","claim":"clm_0F722C0A09FC"},{"label":"Ticker","value":"NVS · NYSE","claim":"clm_FF3D83D13D18"}],"faq":[{"question":"Who is the CEO of Novartis?","answer":"Vasant (Vas) Narasimhan, since 2018, as the AsOf record states with its sources."},{"question":"Where is Novartis headquartered?","answer":"Basel."}],"as_of":"2026-11-08","known_by":null,"since":null,"fact_pages":[{"predicate":"ceo","page":"https://asof.is/record/novartis/ceo","md":"https://asof.is/record/novartis/ceo.md","json":"https://asof.is/v1/entities/novartis/ceo"},{"predicate":"headquarters","page":"https://asof.is/record/novartis/headquarters","md":"https://asof.is/record/novartis/headquarters.md","json":"https://asof.is/v1/entities/novartis/headquarters"},{"predicate":"net_income","page":"https://asof.is/record/novartis/net_income","md":"https://asof.is/record/novartis/net_income.md","json":"https://asof.is/v1/entities/novartis/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/novartis/operating_income","md":"https://asof.is/record/novartis/operating_income.md","json":"https://asof.is/v1/entities/novartis/operating_income"}],"products":[],"coverage":{"entity":"novartis","name":"Novartis","kind":"organization","sources":[{"source":"wikidata","item":"Q507154","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":1114448,"ticker":"NVS","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":59,"open":16,"retracted":0,"first":"1996-01-01","predicates":{"shares_outstanding":{"claims":8,"open":1,"kind":"fact"},"operating_income":{"claims":10,"open":1,"kind":"fact"},"total_assets":{"claims":9,"open":1,"kind":"fact"},"total_equity":{"claims":11,"open":1,"kind":"fact"},"net_income":{"claims":10,"open":1,"kind":"fact"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"listed_on":{"claims":2,"open":2,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"},"ticker":{"claims":2,"open":2,"kind":"identifier"},"registrant_name":{"claims":1,"open":1,"kind":"fact"},"cik":{"claims":1,"open":1,"kind":"identifier"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":58,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":1,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_3312D1223526","predicate":"ceo","value":"Vasant (Vas) Narasimhan","valid_from":"2018-01-01","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ceo: Vasant (Vas) Narasimhan\", as of 2018-01-01. Claim clm_3312D1223526, https://asof.is/claim/clm_3312D1223526, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm.","url":"https://asof.is/claim/clm_3312D1223526","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm","tier":"primary","publisher":"SEC EDGAR 20-F","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-08","quote":"Vasant (Vas) Narasimhan, M.D. Chief Executive Officer since 2018 | Nationality: American | Year of birth: 1976","url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm"}},{"id":"clm_B49F45CDC592","predicate":"cik","value":"0001114448","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis cik: 0001114448\", undated. Claim clm_B49F45CDC592, https://asof.is/claim/clm_B49F45CDC592, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_B49F45CDC592","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_CF6F00F357D4","predicate":"fiscal_year_end","value":"12-31","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis fiscal year end: 12-31\", undated. Claim clm_CF6F00F357D4, https://asof.is/claim/clm_CF6F00F357D4, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_CF6F00F357D4","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_0F722C0A09FC","predicate":"headquarters","value":"Basel","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis headquarters: Basel\", undated. Claim clm_0F722C0A09FC, https://asof.is/claim/clm_0F722C0A09FC, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_0F722C0A09FC","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://textielmuseum.nl/collectie/objecten/?diw-id=brabantcloud_textielmuseum-objecten_09142a=b","tier":"secondary","publisher":null,"published_at":null},{"url":"https://www.wikidata.org/wiki/Q507154","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_A272094EA644","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis listed on: NYSE\", undated. Claim clm_A272094EA644, https://asof.is/claim/clm_A272094EA644, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_A272094EA644","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_626AF6641092","predicate":"listed_on","value":"OTC","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis listed on: OTC\", undated. Claim clm_626AF6641092, https://asof.is/claim/clm_626AF6641092, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_626AF6641092","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_8E9D1CC51F75","predicate":"net_income","value":"13,967,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis net income: 13,967,000,000 United States dollar\", as of 2025-12-31. Claim clm_8E9D1CC51F75, https://asof.is/claim/clm_8E9D1CC51F75, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_8E9D1CC51F75","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_13AEEBEB19A6","predicate":"operating_income","value":"17,644,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis operating income: 17,644,000,000 United States dollar\", as of 2025-12-31. Claim clm_13AEEBEB19A6, https://asof.is/claim/clm_13AEEBEB19A6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_13AEEBEB19A6","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_9ECB34CF2487","predicate":"registrant_name","value":"NOVARTIS AG","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis registrant name: NOVARTIS AG\", undated. Claim clm_9ECB34CF2487, https://asof.is/claim/clm_9ECB34CF2487, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_9ECB34CF2487","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_29E1C56666EB","predicate":"shares_outstanding","value":"1,908,151,679 shares","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis shares outstanding: 1,908,151,679 shares\", as of 2025-12-31. Claim clm_29E1C56666EB, https://asof.is/claim/clm_29E1C56666EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_29E1C56666EB","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_F61B5ED25295","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_F61B5ED25295, https://asof.is/claim/clm_F61B5ED25295, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_F61B5ED25295","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_64105409876F","predicate":"state_of_incorporation","value":"V8","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis state of incorporation: V8\", undated. Claim clm_64105409876F, https://asof.is/claim/clm_64105409876F, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_64105409876F","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_FF3D83D13D18","predicate":"ticker","value":"NVS","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ticker: NVS\", undated. Claim clm_FF3D83D13D18, https://asof.is/claim/clm_FF3D83D13D18, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_FF3D83D13D18","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_75D99E5C33AE","predicate":"ticker","value":"NVSEF","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis ticker: NVSEF\", undated. Claim clm_75D99E5C33AE, https://asof.is/claim/clm_75D99E5C33AE, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.","url":"https://asof.is/claim/clm_75D99E5C33AE","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_0705199BCCFC","predicate":"total_assets","value":"110,949,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total assets: 110,949,000,000 United States dollar\", as of 2025-12-31. Claim clm_0705199BCCFC, https://asof.is/claim/clm_0705199BCCFC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_0705199BCCFC","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_6DC4BBC10979","predicate":"total_equity","value":"46,549,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis total equity: 46,549,000,000 United States dollar\", as of 2025-12-31. Claim clm_6DC4BBC10979, https://asof.is/claim/clm_6DC4BBC10979, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm.","url":"https://asof.is/claim/clm_6DC4BBC10979","accessed":"2026-11-08"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2025, filed 2026-02-04"}},{"id":"clm_684F998583E7","predicate":"website","value":"http://www.novartis.com/","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis website: http://www.novartis.com/\", undated. Claim clm_684F998583E7, https://asof.is/claim/clm_684F998583E7, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q507154.","url":"https://asof.is/claim/clm_684F998583E7","accessed":"2026-11-08"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q507154","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"Novartis.","url":"https://www.novartis.com/"}},{"id":"clm_8BF4C723A097","predicate":"x_username","value":"Novartis","valid_from":"2008-11-06","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novartis x username: Novartis\", as of 2008-11-06. Claim clm_8BF4C723A097, https://asof.is/claim/clm_8BF4C723A097, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q507154.","url":"https://asof.is/claim/clm_8BF4C723A097","accessed":"2026-11-08"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q507154","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"https://x.com/novartis","url":"http://www.novartis.com/"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"page-read":"its source page states the value and the date","sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}